These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 199192)

  • 1. Structural studies on epsilon-prototoxin of Clostridium perfringens type D. Localization of the site of tryptic scission necessary for activation to epsilon-toxin.
    Bhown AS; Habeerb AF
    Biochem Biophys Res Commun; 1977 Oct; 78(3):889-96. PubMed ID: 199192
    [No Abstract]   [Full Text] [Related]  

  • 2. The Molecular Architecture and Mode of Action of
    Titball RW
    Toxins (Basel); 2024 Apr; 16(4):. PubMed ID: 38668605
    [No Abstract]   [Full Text] [Related]  

  • 3. Is
    Titball RW; Lewis N; Nicholas R
    Mult Scler; 2023 Aug; 29(9):1057-1063. PubMed ID: 37480283
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of
    Marshall S; McGill B; Morcrette H; Winlove CP; Chimerel C; Petrov PG; Bokori-Brown M
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356007
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Morcrette H; Bokori-Brown M; Ong S; Bennett L; Wren BW; Lewis N; Titball RW
    NPJ Vaccines; 2019; 4():32. PubMed ID: 31372245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research articleHemolysis in human erythrocytes by Clostridium perfringens epsilon toxin requires activation of P2 receptors.
    Gao J; Xin W; Huang J; Ji B; Gao S; Chen L; Kang L; Yang H; Shen X; Zhao B; Wang J
    Virulence; 2018; 9(1):1601-1614. PubMed ID: 30277122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens ε-Toxin.
    Rumah KR; Ma Y; Linden JR; Oo ML; Anrather J; Schaeren-Wiemers N; Alonso MA; Fischetti VA; McClain MS; Vartanian T
    PLoS Pathog; 2015 May; 11(5):e1004896. PubMed ID: 25993478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic processing and activation of Clostridium perfringens epsilon toxin by caprine small intestinal contents.
    Freedman JC; Li J; Uzal FA; McClane BA
    mBio; 2014 Oct; 5(5):e01994-14. PubMed ID: 25336460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia.
    Bokori-Brown M; Hall CA; Vance C; Fernandes da Costa SP; Savva CG; Naylor CE; Cole AR; Basak AK; Moss DS; Titball RW
    Vaccine; 2014 May; 32(23):2682-7. PubMed ID: 24709588
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Uzal FA; Vidal JE; McClane BA; Gurjar AA
    Open Toxinology J; 2010; 2():24-42. PubMed ID: 24511335
    [No Abstract]   [Full Text] [Related]  

  • 11. A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.
    Li Q; Xin W; Gao S; Kang L; Wang J
    Hum Vaccin Immunother; 2013 Nov; 9(11):2386-92. PubMed ID: 23835363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies.
    Bokori-Brown M; Kokkinidou MC; Savva CG; Fernandes da Costa S; Naylor CE; Cole AR; Moss DS; Basak AK; Titball RW
    Protein Sci; 2013 May; 22(5):650-9. PubMed ID: 23504825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a recombinant epsilon toxoid vaccine against enterotoxemia and its use as a combination vaccine with live attenuated sheep pox virus against enterotoxemia and sheep pox.
    Chandran D; Naidu SS; Sugumar P; Rani GS; Vijayan SP; Mathur D; Garg LC; Srinivasan VA
    Clin Vaccine Immunol; 2010 Jun; 17(6):1013-6. PubMed ID: 20427629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.
    McClain MS; Cover TL
    Infect Immun; 2007 Apr; 75(4):1785-93. PubMed ID: 17261609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex.
    Petit L; Gibert M; Gillet D; Laurent-Winter C; Boquet P; Popoff MR
    J Bacteriol; 1997 Oct; 179(20):6480-7. PubMed ID: 9335299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular typing and epidemiological survey of prevalence of Clostridium perfringens types by multiplex PCR.
    Yoo HS; Lee SU; Park KY; Park YH
    J Clin Microbiol; 1997 Jan; 35(1):228-32. PubMed ID: 8968913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridial enteric diseases of domestic animals.
    Songer JG
    Clin Microbiol Rev; 1996 Apr; 9(2):216-34. PubMed ID: 8964036
    [No Abstract]   [Full Text] [Related]  

  • 18. New gene from nine Bacillus sphaericus strains encoding highly conserved 35.8-kilodalton mosquitocidal toxins.
    Liu JW; Porter AG; Wee BY; Thanabalu T
    Appl Environ Microbiol; 1996 Jun; 62(6):2174-6. PubMed ID: 8787415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Clostridium perfringens epsilon toxin on the cardiovascular system of rats.
    Sakurai J; Nagahama M; Fujii Y
    Infect Immun; 1983 Dec; 42(3):1183-6. PubMed ID: 6315593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence of the amino-terminal part of enterotoxin from Clostridium perfringens type A: identification of points of trypsin activation.
    Richardson M; Granum PE
    Infect Immun; 1983 Jun; 40(3):943-9. PubMed ID: 6303961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.